Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes.
about
Animal models of metabolic syndrome: a reviewAliskiren-attenuated myocardium apoptosis via regulation of autophagy and connexin-43 in aged spontaneously hypertensive rats.Approach to assessing determinants of glucose homeostasis in the conscious mouseRodent models for metabolic syndrome research.Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in miceDPP-4 inhibition with linagliptin ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischemia in type 2 diabetic mice.Direct renin inhibition modulates insulin resistance in caveolin-1-deficient miceMultidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease.TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunctionCardiovascular changes in animal models of metabolic syndromeHepatic extracellular signal-regulated kinase 2 suppresses endoplasmic reticulum stress and protects from oxidative stress and endothelial dysfunctionMyocardial tissue remodeling in adolescent obesityCoronary endothelial dysfunction and mitochondrial reactive oxygen species in type 2 diabetic mice.Aliskiren improves vascular smooth muscle function in the skin microcirculation of type 2 diabetic patients with normal renal functionDirect renin inhibition with aliskiren protects against myocardial ischemia/reperfusion injury by activating nitric oxide synthase signaling in spontaneously hypertensive rats.New class of agents for treatment of hypertension: focus on direct renin inhibition.Nitric oxide: orchestrator of endothelium-dependent responses.The role of renin inhibition in treating the hypertensive patient with diabetes: a summary of preclinical and clinical evidence.Aliskiren improves endothelium-dependent relaxation of thoracic aorta by activating PI3K/Akt/eNOS signal pathway in SHR.Aliskiren prevents and ameliorates metabolic syndrome in fructose-fed rats.Vascular responses to 8-nitro-cyclic GMP in non-diabetic and diabetic mice.Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice.Assessment of glucagon-like peptide-1 analogue and renin inhibitor on the binding and regulation of GLP-1 receptor in type 1 diabetic rat hearts.Metallothionein deficiency exacerbates diabetic nephropathy in streptozotocin-induced diabetic mice.Aliskiren protects against myocardial ischaemia-reperfusion injury via an endothelial nitric oxide synthase dependent manner.The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genesTelmisartan Attenuates Diabetic Nephropathy by Suppressing Oxidative Stress in db/db Mice
P2860
Q28072861-35A9FFA5-BBA6-4980-BE7F-4699EEBEF0B0Q34011428-68E77444-8F29-4D28-8FB6-E2CDBD45A7B6Q34205173-45F001BF-D977-472C-B344-3C6925F9EF14Q34479248-0FB646F1-5BF6-43DB-B3FC-176A29CE2378Q34872407-37E37323-2BEB-411A-9C3C-27DBBB6218A8Q35690114-71D6F5D4-A62E-4B20-B15D-5D9AB40CC02BQ36456701-963095D2-6A4D-4DEF-9B1F-BCC3CC0013F8Q36470320-95210F8F-2EC9-4B6D-8955-5457395336FDQ36816043-324D6172-D62F-4A73-B673-BDA60D7C9905Q36825744-165F4D8E-6BAC-4688-9F68-E97B87478967Q37310401-3E44FD7C-0718-438C-87BE-8D932EEFBD68Q37310497-209F1543-85FA-4FC7-BB03-934A7D400024Q37341923-85173891-2A49-4BE7-AA54-675733935118Q37619165-3F5CB67E-9B09-4E32-8E89-236DDC17766BQ37648622-4A5DCDC0-FF97-4F45-BBB9-175BD2C5CF12Q37801292-1D1AB220-45E2-459A-A6BE-B4DB1F2C5925Q37927098-0DD633D2-D35B-4DF7-A16C-E12FBF8EA7F1Q37980260-415AA590-70D1-4491-BF50-AE3C43B16149Q40067806-39531F90-2D30-4C5C-8313-7BB419C2BDF1Q40418079-E73DD570-DC09-4EFF-842E-0D37F81D7F7BQ42002822-0D408A6E-7D13-4F6E-9350-030DE5489788Q42006157-145CA5B1-1BCB-41D9-B424-5110AA187018Q42121004-06A010F3-D9F4-4680-A464-59CFD9E53CA5Q46979061-B12BE37E-70E2-49F3-9204-84EBC2339CA4Q47369456-FD7E7064-39C6-4F59-9702-4C4B39A30E30Q56985191-C26295F2-8813-424A-9586-F250C7A4D9C3Q58366410-98888849-36B5-4FA8-A990-848151AD37AF
P2860
Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Aliskiren prevents cardiovascu ...... f obesity and type 2 diabetes.
@en
Aliskiren prevents cardiovascu ...... f obesity and type 2 diabetes.
@nl
type
label
Aliskiren prevents cardiovascu ...... f obesity and type 2 diabetes.
@en
Aliskiren prevents cardiovascu ...... f obesity and type 2 diabetes.
@nl
prefLabel
Aliskiren prevents cardiovascu ...... f obesity and type 2 diabetes.
@en
Aliskiren prevents cardiovascu ...... f obesity and type 2 diabetes.
@nl
P2093
P921
P1433
P1476
Aliskiren prevents cardiovascu ...... f obesity and type 2 diabetes.
@en
P2093
S Kim-Mitsuyama
T Nakamura
Y Tokutomi
P2888
P304
P356
10.1007/S00125-009-1575-5
P577
2009-11-06T00:00:00Z